Aspen Pharmacare Asset Turnover 2017-2024 | APNHY
Aspen Pharmacare asset turnover from 2017 to 2024. Asset turnover can be defined as the amount of sales or revenues generated per dollar of assets. The asset turnover ratio is an indicator of the efficiency with which a company is deploying its assets.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $2.392B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $19.196B | 6.94 |
| Dr Reddy's Laboratories (RDY) | India | $11.186B | 20.30 |
| BridgeBio Pharma (BBIO) | United States | $6.488B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.775B | 14.41 |
| Bausch Health Cos (BHC) | Canada | $1.662B | 1.22 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.145B | 7.63 |
| Personalis (PSNL) | United States | $0.445B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.437B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.093B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.022B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.005B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |